Enableit company information, Employees & Contact Information

Rheumatoid Meningitis Presenting Without Apparent Joint Symptoms: A Case Report Highlighting the Usefulness of Musculoskeletal Ultrasound Cureus

Daily Digest: Top news from October 28 Insurance Insider US

Consumer confidence dips as markets rally The Real Economy Blog

Little Amélie, or the Character of Rain, from GKIDS Cinema Daily US

EY US - Home | Building a better working world EY

Unusual Presentation of Giant Cell Arteritis With Localised Temporal Artery Aneurysm Cureus

E&S will continue to be ‘big portion’ of California business post-wildfires: CinFin Insurance Insider US

Driving change: The new roadmap for automotive retail transformation RSM

Massive Nationwide Cancer Charity Fraud Scheme Serves as Warning Oncology News Central

American Rheinmetall Munitions and Solugen to formalize partnership Rheinmetall

Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets Cureus

Everest stock drops 11% following AIG deal announcement and Q3 earnings Insurance Insider US

Holly Starks Acquires the Flumberico Brand, Expanding the Vision Behind flumberico.us.com Yahoo Finance

AdvaMed Code of Ethics® AdvaMed® - Advanced Medical Technology Association®

FLUMIST® (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery AstraZeneca US

BofA Launches ‘Golf with Us’ to Bring Affordable Rounds to More Than 50,000 Youth Nationwide Bank of America

Car donation charity fined millions, accepts fundraising restrictions in Colorado and 18 other states CBS News

U.S.A. Home Hitachi Global

Scam charity claiming to donate money to breast cancer support shut down WECT

Empowering Action in Asthma Care This Season and Beyond AstraZeneca US

iPR Pharmaceuticals Earns its 1st EPA’s ENERGY STAR® Certification for Superior Energy Efficiency AstraZeneca US

AstraZeneca impact in the US AstraZeneca US

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer AstraZeneca US

Our impact, our people AstraZeneca US

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D AstraZeneca US

Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial AstraZeneca US

AIRSUPRA ® (albuterol/budesonide) US prescribing information updated to reflect the statistically significant severe exacerbation risk reduction in patients with mild asthma compared with albuterol AstraZeneca US

Kars-R-Us scam using breast cancer support shut down The Center Square

Delaware AG joins lawsuit against 'deceptive' breast cancer fundraising operation The News Journal

CONSUMER PROTECTION NEWS: FTC, 19... VitalLaw.com

Nationwide Fake Cancer Charity Scam Busted, Kars-R-Us.com Inc. Accused Hoodline

Statistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthma AstraZeneca US

Partnerships in Motion: How Cross-Sector Collaboration is Powering Broader Clinical Trial Representation AstraZeneca US

Trump calls for using US cities as a ‘training ground’ for military in unusual speech to generals Federal News Network

Cambrian Works Selects Astroscale U.S. as its Mission Partner for NASA Swift Observatory Boost Mission Concept Study SpaceNews

Be careful with online Joann closure sales Canton Repository

Luv n' care Recalls Nuby Stroller Fans Due to Laceration Injury Hazard U.S. Consumer Product Safety Commission (.gov)

American Rheinmetall secures order for T-158 tracks Rheinmetall

Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" PR Newswire

Do Not Shop On Any Website That’s On This List Forbes

Qilin affiliates spear-phish MSP ScreenConnect admin, targeting customers downstream Sophos News

US Com Sec Lutnick says again on tariffs that 10 is baseline, no one’s going below 10 investingLive

Rheinmetall completes acquisition of Loc Performance in the USA Rheinmetall

Announcing the 2024-2025 US ACT on Health Equity Community Investments Recipients AstraZeneca US

Collective Action to Advance Health Equity AstraZeneca US

FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis AstraZeneca US

What science can do AstraZeneca US

AIRSUPRA (PT027) approved in the US for asthma AstraZeneca US

Announcing the 2023 Power of Us Award winners AstraZeneca US

Scot Anderson Womble Bond Dickinson

The Real Economy: October 2025 RSM

TAGRISSO® (osimertinib) granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer AstraZeneca US

Tracy A. Bacigalupo Womble Bond Dickinson

Leadership RSM

Join RSM's global workforce in El Salvador RSM

Careers AstraZeneca US

Investigator Sponsored Studies (ISS) Program Novo Nordisk U.S. Website

Rewards and benefits RSM

AIRSUPRA® (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent or mild persistent asthma in BATURA Phase III trial AstraZeneca US

Who We Are Otsuka US

FluMist approved for self-administration in the US AstraZeneca US

WAINUA (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis AstraZeneca US

Nonprofit and education RSM

ispace-US and Rhea Space Activity Sign Payload Services Agreement Aimed at Expanding Deep Space Technological Capabilities ispace

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH AstraZeneca US

Contact Us AstraZeneca US

ispace - U.S. Announces new U.S. Headquarters, Unveils APEX 1.0 Lunar Lander, Provides Updates on Mission 3 ispace

TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer AstraZeneca US

Product patents Novo Nordisk U.S. Website

Alexander P. Wharton Womble Bond Dickinson

FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients AstraZeneca US

Portraits of Lung Cancer AstraZeneca US

TAGRISSO® (osimertinib) plus chemotherapy extended median progression-free survival by nearly 9 months in EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial AstraZeneca US

ispace-U.S. Accelerates its Mission 3 Utilizing Agile Development with Fusion by Stoke Space ispace

Agreement to takeover US vehicle specialist Loc Performance Rheinmetall

SAPHNELO (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus AstraZeneca US

BYDUREON BCise (exenatide extended-release) approved in the US for the treatment of type 2 diabetes in pediatric patients ages 10 years and older AstraZeneca US

AstraZeneca announces start of recruitment in two new Phase III trials evaluating SAPHNELO – in cutaneous lupus erythematosus (LAVENDER) and in idiopathic inflammatory myopathies (JASMINE) AstraZeneca US

AstraZeneca’s Aradhana Sarin Named to CNBC’s 2024 Changemakers: Women Transforming Business List AstraZeneca US

Personified: Bridget Therriault AstraZeneca US

Improving access and affordability Novo Nordisk U.S. Website

LOKELMA® granted Fast Track Designation in the US to reduce cardiovascular outcomes in patients on chronic hemodialysis with hyperkalemia AstraZeneca US

Taking the Wheel in Diverse Clinical Trial Recruitment: Introducing AZ's AIRE Mobile Unit AstraZeneca US

AstraZeneca shares progress on LYNPARZA™ (olaparib) tablets in the US AstraZeneca US

ispace-U.S. to use Swedish Space Corporation’s Lunar Ground Station Network for its M3 Lunar Mission ispace

US FDA approves new easy-to-use, once-weekly BYDUREON® BCise™ injectable medicine for patients with type-2 diabetes AstraZeneca US

AstraZeneca in the United States AstraZeneca US

ispace-U.S. Announces Official Launch of Data Relay Service Enabled by Two Relay Satellites ispace

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know AstraZeneca US

Express launches US .com site The Media Leader

Bart LaCount Appointed Chief Marketing Officer and Matt Rubin Appointed Chief Digital Officer of Popeyes® U.S. & Canada Popeyes Newsroom

Unaccompanied Child Migrants in U.S. Communities, Immigration Court, and Schools migrationpolicy.org

Diabetes Pen Needles Novo Nordisk U.S. Website

AstraZeneca US and Health Equity: Today & Tomorrow AstraZeneca US

Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin A Nephropathy Business Wire

Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn™, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms Business Wire

What is known about latest leak of U.S. secrets Reuters

FASLODEX® (fulvestrant) receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib AstraZeneca US

Meet our 2022 Power of Us Award Winners AstraZeneca US

The truth behind the ‘He Gets Us’ ads for Jesus airing during the Super Bowl CNN